Closed call · historical reference
Scope:Specific challenge: Promising pre-clinical nano-medicine proof-of-concepts have been developed for the therapy of cancer, but their translation into clinical therapies remains a major challenge. An important bottleneck is up-scaling under Good Manufacturing Practice (GMP) conditions for the p…
Topics
Partner types
clinical_research_consortium, healthcare_provider, research_institution, university
